SESSION TITLE: Heme and infection ICU
SESSION TYPE: Original Investigation Slide
PRESENTED ON: Sunday, October 23, 2016 at 07:30 AM - 08:30 AM
PURPOSE: Standard treatment of patients with venous thromboembolism (VTE) is anticoagulation, which increases the risk of bleeding. To evaluate major bleeding (MB) in a post-marketing setting of VTE patients treated with rivaroxaban and to examine potential risk factors.